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Objectives. This study sought to investigate the effect of coro- 
nary angioplasty on chronic hypoperfusion-induced endothelial 
dysfunction in patients with coronary heart disease. 
Background. The endothelium is an important component for 
organ flow regulation. Ischemia with or without reperfusion is 
known to cause endothelial dysfunction. We tested the hypothesis 
that chronic hypoperfusion impairs endothelial function in the 
angiographically normal coronary artery segment distal to steno- 
sis and that the impairment by chronic hypoperfusion is reduced 
by coronary angioplasty. 
Methods. In 13 patients with stable angina pectoris, substance 
P (10, 30 and 100 pmol) and nitroglycerin (200/tg) were sequen- 
tially infused into the coronary artery in a cumulative manner on 
the day after coronary angioplasty. In 10 of these patients, 
vascular responses to these agents were again investigated 3 
months after angioplasty. Changes in vascular diameter were 
evaluated in vessels located proximal and distal to the target 
lesion, both of which were angiographically normal, by performing 
computer-assisted quantitative coronary angiography. In five pa- 
tients, the transstenotic pressure gradient was also measured with 
a pressure sensor-mounted guide wire before angioplasty. 
Results. On the day after angioplasty, the magnitude of dilation 
by substance P in distal segments was significantly less than that 
in proximal segments and inversely correlated with the transste- 
notic pressure gradient (p < 0.05) and lesion stenosis (p < 0.05). 
There was no difference in nitroglycerin-induced vasodilation 
between the two vessel segment groups. Three months later, the 
impaired response to substance P in the distal segment was 
restored to normal. 
Conclusions. We conclude that chronic hypoperfusion impairs 
endothelium-dependent dilation of coronary artery distal to crit- 
ical stenosis in patients with ischemic heart disease and that 
coronary angioplasty ameliorates the endothelial dysfunction 
within 3 months. 
(JAm Coil Cardiol 1996;27:30-7) 
The endothelium protects organ circulation from vasoconstric- 
tion and thrombus formation by releasing endothelium- 
derived relaxing factor (1,2), which has been identified as nitric 
oxide (3,4) or related nitrosyl compounds (5). Nitric oxide is 
released in the basal condition (6), and its release is enhanced 
by an increase in shear stress and by exposure to various 
agonists (1). Endothelium-dependent vasodilation is impaired 
in several pathologic conditions, such as atherosclerosis (7-10), 
hypertension (11), hypercholesterolemia (12)and congestive 
heart failure (13). Increasing evidence has shown (14-18) that 
ischemia with or without reperfusion or hypoxia is an impor- 
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tant factor that impairs endothelial functions in various spe- 
cies, including human coronary artery. Thus, it is probable that, 
in patients with ischemic heart disease, vascular segments 
distal to a stenotic lesion that are exposed to low perfusion are 
functionally defective in terms of mediation of endothelium- 
dependent vasodilation. 
Coronary angioplasty has been widely performed and es- 
tablished as an effective remedy for ischemic heart disease 
(19). Relief from ischemia by coronary angioplasty may ame- 
liorate the low perfusion-induced functional impairment of 
coronary endothelium. However, there is no evidence to date 
that relief from hypoperfusion improves endothelial dysfunc- 
tion. Accordingly, the goal of the present study was to test the 
hypothesis that endothelium-dependent vasodilation in angio- 
graphically normal vascular segments exposed to chronic hy- 
poperfusion is impaired in ischemic heart disease and that 
relief from chronic ischemia by coronary angioplasty amelio- 
rates endothelial dysfunction. In the present study, endothelial 
function was prospectively evaluated 1 day after and 3 months 
after angioplasty in vascular segments located istal and prox- 
imal to critical stenosis by infusing substance P,which has been 
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Table 1. Clinical Characteristics of 13 Male Study Patients 
Left Ventriculography 
Coronary % Diameter Stenosis Transstenotic 
Regional Collateral Angioplasty Pressure 
Pt No./ EF Wall Circulation Before After Gradient Follow- 
Age Diagnosis Risk Factors (%) Motion* Grader Method Targets Angioplasty Angioplasty (ram Hg) Up Study 
1/64 AP HT, SM 73 Normal 0 Balloon 6 79 46 0 Yes 
2/61 OMI, AP SM 57 2, 3, 4, 6, R 1 Balloon 7 95 38 38 Yes 
3/'74 OMI, AP DM, HL 70 4, 5, R 0 Balloon 7 67 29 37 Yes 
4/66 AP None 79 Normal 1 Balloon 3 95 38 34 Yes 
5,/59 AP None 75 Normal 0 Balloon 6 64 20 29 Yes 
6,/63 AP HT, SM 75 Normal 0 Balloon 6 80 43 - -  Yes 
7/65 AP HT 83 Normal 0 Balloon 9 81 50 - -  No 
8/'68 AP DM, HT 78 Normal 0 DCA 6 73 25 - -  Yes 
9/52 AP HL 72 Normal 0 DCA 6 84 11 - -  Yes 
10/66 OMI, SMI DM, SM 60 5, N 0 Balloon 4 90 0 - -  Yes 
11/'67 AP None 58 5, 7, R 2 Balloon 3 100 36 - -  Yes 
12,,'74 OMI, SMI DM, SM HU 66 4, 5, R 2 Balloon 1 99 31 - -  No 
13,,'50 AP SM, FH 74 Normal 0 DCA 6 67 8 - -  No 
Mean 64 71 83 29 28 
SE +2 _+2 z4 _+4 _+7 
*Based on American Heart Association guidelines (21). tAccording to modified method of Rentrop et al. (22). SLocation of angioplasty target lesion according 
to American Heart Association guidelines (21). AP - angina pectoris; Balloon = balloon angioplasty; DCA = directional coronary atherectomy; DM - diabetes 
mellitus; EF - ejection fraction; FH - family history of ischemic heart disease; HL = hyperlipidemia; HT - hypertension; HU - hyperuricemia; N - none in wall 
motion; OMI = old myocardial infarction; R - reduced wall motion: SM smoking; SMI - silent myocardial ischemia; - -  not measured. 
known to act selectively on endothelium, leading to endothelium- 
dependent vasodilation (8,9,20). 
Methods 
Study patients. Thirteen patients who underwent coronary 
angioplasty (balloon angioplasty or directional coronary 
atherectomy) at Tohoku University Hospital or Iwate Prefec- 
tural Central Hospital for treatment of chronic stable angina 
were enrolled in the study. Inclusion criteria were 1) primarily 
successful angioplasty; and 2) angiographically normal vessels 
distal to the target of angioplasty lesion. Patients who under- 
went bypass graft surgery, repeat angioplasty for a restenotic 
lesion or staged angioplasty were excluded from the study, as 
were patients with acute ischemic events, such as acute myo- 
cardial infarction and unstable angina. All drugs were discon- 
tinued for at least 48 h before angioplasty and before follow-up 
angiography. All patients gave written informed consent o 
participate in the study. 
Clinical characteristics of the enrolled patients are shown in 
Table 1 (13 men, 50 to 74 years old, mean [_+SE] age 64 _+ 2). 
All patients had transient signs of myocardial ischemia on 
exercise lectrocardiography or stress thallium scintigraphy, or
both. Two patients (Patients 10 and 12) had only silent 
myocardial ischemia without pain. The remaining 11 patients 
had anginal pain. Four patients (Patients 2, 3, 10 and 12) had 
a history of previous myocardial infarction. Ten patients 
underwent balloon angioplasty, and three underwent direc- 
tional coronary atherectomy. All the target lesions of angio- 
plasty were short segmental stenoses, located in the left 
anterior descending (n = 9) or right coronary artery (n = 4). 
Study protocols. At diagnostic atheterization, left ven- 
triculography and coronary angiography were performed. 
Ejection fraction, regional wall motion and percent diameter 
stenosis of the culprit lesion were evaluated. Descriptions of 
regional wall motion abnormality and nomenclature of coro- 
nary vascular segments were based on the reporting system of 
the American Heart Association (21). Collateral circulation 
was graded according to Rentrop et al. (22), follows: 0 = no 
visible filling of any collateral channels; 1= collateral filling of 
branches of the vessel to be dilated without any dye reaching 
the epicardial segment of that vessel; 2 = partial collateral 
filling of the epicardial segment of the vessel being dilated; 3 = 
complete collateral filling of the vessel being dilated. 
Balloon angioplasty or directional coronary atherectomy was 
performed by a standard technique using the femoral ap- 
proach. After completion of angioplasty, heparin and nitro- 
glycerin were continuously infused to prevent acute coronary 
occlusion. Calcium antagonists or other antianginal agents 
were not administered. One day after angioplasty, coronary 
angiography was performed to investigate the effect of sub- 
stance P on coronary artery diameter. Continuous infusion of 
nitroglycerin was stopped for at least 3 h before coronary 
angiography. 
Coronary angiography was performed by the Judkins 
method in the projection that best displayed the coronary 
anatomy. The image intensifier was not moved during the 
infusion of substance P and nitroglycerin. First, 5 ml of the 
vehicle of substance P was infused into the coronary artery for 
1 rain. Two minutes after the completion of the infusion, the 
coronary angiogram was obtained. Three doses of substance P 
(10, 30, and 100 pmol in 5 ml) were sequentially infused into 
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the coronary artery for 1 min in a cumulative manner. An 
angiogram was obtained 2min after each dose of substance P. 
Thereafter, 200 ~g of nitroglycerin was infused into the 
coronary artery for 30 s, and an angiogram was again obtained 
2 rain after the infusion. After completion of coronary angiog- 
raphy, antianginal gents, including calcium channel blockers, 
were resumed. 
Three months after angioplasty (90 z 8 days), a follow-up 
study was performed in 10 patients. Three patients were 
excluded from the follow-up study because of the occurrence 
of restenosis (>75% diameter stenosis, Patients 7 and 13) or 
rejection of follow-up angiography (Patient 12). All drugs were 
discontinued for at least 48 h before angiography. The vehicle, 
three doses of substance P and nitroglycerin were infused into 
the coronary artery, and coronary angiograms were obtained as 
previously described. The protocol of the present study was 
approved by the ethics committee ofTohoku University School 
of Medicine. 
Quantitative angiographic analysis. Coronary arterial u- 
men diameters were measured by the cinevideodensitometric 
analysis system (Coronary Analyzer, model XR-70, Van- 
guard). Analysis was performed during the end-diastolic phase. 
The size of the coronary catheter was used for calibration of 
the diameter measurement. To validate our method of mea- 
suring coronary artery diameters, the intraobserver and inter- 
observer differences of measured values were evaluated. These 
differences were negligible (intraobserver correlation: r = 
0.998, p = 0.0001, regression line y = 0.996x + 0.006; 
interobserver correlation: r = 0.997, p = 0.0001, regression 
line y = 0.995x + 0.015). 
Two vessel segments (one distal, one proximal) were chosen 
for analysis for each patient as follows. The distal segment was 
defined as a segment of coronary artery distal to the target 
lesion of angioplasty or its branch. The proximal segment was 
defined as a segment of coronary artery proximal to the target 
lesion or its branch. In each patient we attempted tochoose a 
pair of vessel segments nearly identical in size to exclude the 
size-dependency factor of vasodilation by substance P and 
nitroglycerin. 
Measurement of transstenotic pressure gradient. In five 
patients, the transstenotic pressure gradient was measured by a 
guide wire with a miniaturized pressure sensor on the tip 
(0.018 in. [0.46 mm]) (Pressure Guide, RadiMedical Systems, 
Uppsala, Sweden) and pressure monitor system (model PGA- 
10, RadiMedical Systems) just before angioplasty. A detailed 
description of the transstenotic pressure gradient measure- 
ment system has been previously reported (23). 
The pressure signal was calibrated immediately before 
insertion of the pressure guide wire. After intubation of the 
coronary artery with a guiding catheter, a 0.018-in. guide wire 
was advanced through the target stenosis, and the balloon was 
positioned at the target stenosis. Then, the guide wire was 
withdrawn and replaced with the pressure guide wire so that 
the pressure sensor element of the pressure guide wire was 
located istal to the stenosis. Thereafter, the balloon catheter 
was withdrawn to avoid producing a transstenotic pressure 
gradient, and the distal pressure was measured. Then, the 
pressure guide wire was pulled back to where the pressure 
sensor was proximal to the stenotic lesion, and the coronary 
pressure was again measured. The balloon catheter was repo- 
sitioned across the stenosis, and angioplasty was performed. 
Drugs. Substance P and nitroglycerin were purchased from 
Sigma and Nihon Kayaku Co. (Tokyo, Japan), respectively. 
Substance P was dissolved with distilled water (0.1 mmol/liter), 
and 1-ml aliquots were stored at -20°C until use. The aliquot 
was dissolved with saline for the desired concentrations ju t 
before intracoronary infusion. Nitroglycerin was freshly dis- 
solved with saline to 40 ~g/ml. 
Statistical analysis. Results are expressed as mean value ___ 
SE. Serial changes in coronary diameter in response to sub- 
stance P and nitroglycerin were analyzed by analysis of vari- 
ance for repeated measures, followed by a Bonferroni multiple 
comparison test (24). Vascular diameters measured 2 min after 
vehicle infusion were considered baseline diameters, and vas- 
cular responses to the vasoactive agents were evaluated by 
percent change in diameter. Differences in diameter changes 
between distal and proximal segments were compared by the 
Student t test for paired samples. Data obtained 1day after and 
3 months after angioplasty were compared by the Student t test 
for paired samples. Simple linear regression analysis was 
performed to evaluate interobserver and intraobserver differ- 
ences of diameter measurement and to evaluate the effect of 
the angioplasty procedure (coronary occlusion duration, num- 
ber of balloon inflations and maximal balloon inflation pres- 
sure during balloon angioplasty). Simple linear regression 
analysis was also performed to evaluate the correlation be- 
tween vascular esponses 1day after angioplasty and transste- 
notic pressure gradient or percent diameter stenosis measured 
before angioplasty. A p value <0.05 was considered significant. 
Resu l ts  
Patient profile. All patients had an ejection fraction >55% 
(mean 71 _+ 3%) (Table 1). Regional asynergy was present in 
five patients (Patients 2, 3, 10, 11, 12). Mean diameter stenosis 
of the target lesion was 83 _+ 4% before and 29 _+ 4% after 
angioplasty. Mean coronary occlusion duration during balloon 
angioplasty was 6.5 + 1.1 rain (range 2 to 13). Mean number of 
balloon inflations and maximal inflation pressure were 3.6 + 
0.6 atm (range 2 to 7) and 8.1 _+ 0.9 atm (range 4 to 14), 
respectively. Collateral circulation was detected in four pa- 
tients (Patients 2, 4, 11, 12) before angioplasty. At follow-up, 
target lesion percent diameter stenosis was 41 +_ 6% in the 10 
patients in whom a follow-up study was performed. 
Vascular responses to substance P and nitroglycerin 1 day 
after coronary angioplas~. There was no difference in base- 
line diameter between distal (n = 13, 2.0 + 0.3 ram) and 
proximal segments (n = 13, 2.2 _+ 0.3 ram). The effect of 
vehicle on vascular diameter was evaluated in 11 patients. 
There was no difference in diameter before and after vehicle 
infusion in distal (1.9 _+ 0.2 vs. 2.0 _+ 0.2 mm, respectively) or 
proximal segments (2.2 _+ 0.3 vs. 2.2 -2_ 0.3 ram, respectively). 
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Figure 1. Effect of intracoronary infusion of substance P and nitro- 
glycerin (TNG, 200 /zg) on coronary artery diameter 1 day after 
coronary angioplasty. Substance P dilated vascular segments proximal 
to the target lesion (open circles) in a dose-dependent manner but did 
not dilate distal segments (solid circles). There was no difference in the 
magnitude of nitroglycerin-induced dilation between proximal and 
distal segment groups. *p < 0.05 versus baseline diameter, tp < 0.05 
versus distal segments. 
60,  
"~ 40 
~5 
.=_ 20 
~ o 
m 
~_ -20  
-40  
o 
0 10 20 30 40 
Transstenotic Pressure Gradient (mrnHg) 
601 
401 
zOl 
ol 
-2Ol 
-40' 
60 
o 
o o co o 
o 
o 
o 
i i i 
70 80 90 100 
Percent Diameter Stenosis 
Figure 2. Left, Scatterplot showing correlation between transstenotic 
pressure gradient measured just before angioplasty and vascular 
responses to intracoronary substance P (100 pmol) in the distal 
vascular segments (n = 5) 1 day after angioplasty. Simple regression 
analysis indicated a significant correlation (r = 0.93, y = -2.035x + 
61.04, p < 0.05). Right, Scatterplot showing correlation between 
percent diameter stenosis and vascular esponses of the distal seg- 
ments to intracoronary substance P (100 pmol). Simple regression 
analysis indicated a significant correlation (r = 0.55, y = -1.039x + 
94.34, p < 0.05). 
Figure 1 shows the vascular esponses to substance P and 
nitroglycerin 1 day after angioplasty in patients who also 
underwent follow-up study. Dilation in response to substance P 
in the proximal segment was dose dependent. Dilation in 
response to 100 praol of substance P was almost identical to 
that in response to nitroglycerin, suggesting that the maximal 
dose of substance P produced an almost maximal relaxation of 
vascular smooth muscle. In contrast, the distal vascular seg- 
ments did not dilate in response to substance P, although they 
did dilate in response to nitroglycerin. There was no difference 
in nitroglycerin-induced dilation between the distal and prox- 
imal segments. These results demonstrate hat the attenuated 
responses to substance P in distal segments were related to 
endothelial dysfunction. The difference in vascular esponses 
to substance P between distal and proximal segments reached 
statistical significance at the dose of 100 praol. 
The mean value of the transstenotic pressure gradient (n = 
5) was 28 + 7 ram Hg (range 0 to 38 rata Hg). Substance 
P-induced dilation in distal segments was closely correlated 
with pressure gradient (r = 0.93, p < 0.05) (Fig. 2, left) and 
with percent of diameter stenosis (r - 0.55, p < 0.05) (Fig. 2, 
right), although the correlation coefficient for percent diame- 
ter stenosis was smaller than that for pressure gradient. 
To evaluate the possibility that the angioplasty procedure 
itself affected endothelial function in the distal segments, we 
tested the correlation between the balloon angioplasty pro- 
cedures (coronary occlusion duration, number of inflations and 
maximal balloon inflation pressure) and substance P- 
induced ilation (100 praol). None of these factors correlated 
with the substance P-induced dilation (coronary occlusion 
duration: r = 0.031, p = 0.933; number of inflations: r = 0.092, 
p = 0.801; maximal balloon inflation pressure: r = 0.086, p = 
0.813). 
Vascular responses to substance P and nitroglycerin at 
follow.up study. There was no difference inbaseline diameter 
at next-day or follow-up study in either the distal (2.0 __ 0.2 vs. 
1.8 -+ 0.2 mra, respectively) orproximal segments (2.2 _+ 0.3 vs. 
2.0 + 0.3 ram, respectively). Vascular esponses to substance P 
and nitroglycerin at follow-up are shown in Figure 3. Both 
distal and proximal vascular segments dilated in response to 
substance P in a dose-dependent manner. There was no 
difference between distal and proximal segments in diameter 
changes. 
Figure 4 compares the responses of the distal segments at 
next-day and follow-up study. Substance P-induced vasodila- 
tion was greater at follow-up than at next-day study, but the 
magnitude of nitroglycerin-induced dilation was nearly the 
same at both study phases. 
When four patients with regional wall motion abnorraaliW 
were evaluated separately from all 10 patients tudied, the 
same amelioration of endothelial dysfunction was observed 
Figure 3. Vascular responses of distal (solid circles) and proximal 
segments (open circles) to substance P and nitroglycerin (TNG) 3 
months after angioplasty. There were no differences between the two 
groups. *p < 0.05 versus baseline diameter. 
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Figure 4. Vascular responses of distal segments 1 day after (open 
bars) and 3 months after angioplasty (striped bars) to substance P 
(100 pmol) and nitroglycerin (200 p~g). Substance P-induced ilation 
was greater at 3 months after than 1 day after angioplasty. Conversely, 
there was no difference in nitroglycerin-induced dilation between the 
two study phases. *p < 0.05 versus 1 day after angioplasty. 
(substance P-induced dilation from -10 +_ 7.1% to 37.7 +_ 
10.2%, p < 0.05; nitroglycerin-induced dilation from 46.2 _+ 
19.6% to 40.8 _+ 9.3%, p = NS). 
Discuss ion  
The major findings of the present study are as follows: 1) In 
patients with chronic stable angina pectoris, endothelium- 
dependent vasodilation produced by substance P is impaired in 
angiographically normal coronary artery segments located 
distal to the critical stenosis. 2) The magnitude of endothelial 
dysfunction is correlated with the transstenotic pressure gra- 
dient and lesion stenosis measured before coronary angio- 
plasty. 3) Angioplasty ameliorates the endothelial dysfunction 
within 3 months. 
Substance P-induced vasodilation. We used substance P
to evaluate ndothelial function because this substance po- 
tently and specifically acts on the endothelium (8,9,20). Sub- 
stance P-induced vasodilation is abolished by denudation of 
endothelium (8,9,20), and receptors for substance P have been 
detected only in the endothelium but not in the media (25). 
Crossman et al. (26) investigated the effect of substance P on 
human coronary artery vasomotion i  normal subjects and 
showed dilation of epicardial conduit vessels and increases in 
coronary flow. 
Acetylcholine isanother tool for investigating endothelium- 
dependent vasodilator responses. However, the effect of ace- 
tylcholine on vascular segments is different from that of 
substance P.Acetylcholine dilates normal coronary arteries but 
constricts those with ischemic heart disease, even if the vascu- 
lar segments tudied are angiographically normal (27). Im- 
paired acetylcholine-induced vasodilation may be a marker of 
the very early phase of atherosclerosis, which cannot be 
detected by angiography (28,29). Conversely, angiographic 
study (25) has shown that substance P dilates atherosclerotic 
vascular segments to the same extent as normal vascular 
segments. Although a study of vascular ings (10) has demon- 
strated attenuated dilation by substance P in atherosclerotic 
vessels, the degree of attenuation was relatively modest. Sev- 
eral previous studies (8,9) have demonstrated that vascular 
segments in which acetylcholine-induced vasodilation was 
abolished still dilated in response to substance P. It is likely 
that substance P is more potent han acetylcholine in terms of 
stimulating release of endothelium-derived relaxing factor. It is 
known that in patients with ischemic heart disease, anglo- 
graphically normal vascular segments have extended athero- 
sclerosis (30). Thus, in our patients the vessels tudied would 
have constricted in response to acetylcholine, and the constric- 
tion would have masked the effect of angioplasty on endothe- 
lial function. The difference in the vasomotor effects of the two 
agents may result from differences in signal transduction or
their selectivity to endothelium, or both. 
Attenuated endothelium-dependent vasodilation in angio- 
graphically normal vascular segments distal to stenosis. In 
the present study, substance P-induced vasodilation in the 
angiographically normal vascular segment distal to the target 
lesion of angioplasty was attenuated compared with nondilated 
normal segments. Because vasodilation by nitroglycerin, which 
acts directly on vascular smooth muscle, was preserved, the 
vasomotor impairment is considered to occur in the endothe- 
lium. 
Ku (14) first demonstrated that ischemia with reperfusion 
impairs endothelium-dependent vasodilation induced by 
thrombin in the dog coronary artery. Since then, other inves- 
tigators have shown that this phenomenon can also be ob- 
served with other agonists (15) and that even brief ischemia 
functionally disrupts the endothelium without morphologic 
changes (31). In an animal study, Tsao et al. (32) attributed the 
cause of the ischemia/reperfusion-induced en othelial dys- 
function to superoxide anion on the basis of the observation of 
the preventive ffect of superoxide dismutase treatment 
against endothelial dysfunction. However, in these studies, the 
coronary artery was completely occluded. Conversely, in our 
study, the coronary artery was only partially occluded, except in 
one patient (83% reduction i  diameter in mean value). Some 
mechanism other than superoxide-induced ndothelial dys- 
function should therefore be considered. One probable mech- 
anism is downregulation f constitutive nitric oxide synthase in 
the vascular endothelium distal to stenosis. 
Exposure of the distal segment to low perfusion pressure 
may underlie the mechanism ofdownregulation f nitric oxide 
synthase. Actually, the transstenotic pressure gradient at rest- 
ing state measured by the pressure guide wire was negatively 
correlated to the substance P-induced vasodilation. Although 
Galle et al. (33) recently showed that acute low perfusion 
pressure itself did not affect acetylcholine-induced vasodila- 
tion, the long-term effect of low perfusion pressure on the 
endothelial function has not been investigated. 
Decreased shear stress induced by the low flow state 
produced by critical stenosis may also account for the down- 
regulation of the enzyme. Nishida et al. (34) demonstrated the 
upregulation of constitutive nitric oxide synthase by shear 
stress. However, Miller et al. (35) showed that a low flow state 
does not alter agonist-induced endothelium-dependent vaso- 
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dilation, whereas a high flow state enhances dilation. To date, 
the effect of low shear stress on endothelial function in 
atherosclerotic vessels remains to be elucidated. It is difficult o 
discriminate the effect of low perfusion pressure from that of 
the low flow state in vivo. 
Previous tudies (16-18) have proposed the possibility that 
hypoxia impairs the release or synthesis of endothelium- 
derived relaxing factor in blood vessels. Hashimoto et al. (17) 
showed that substance P-induced vasodilation isdependent on 
oxygen partial pressure with a threshold of 35 mm Hg. 
However, in the present study, only 1 of 13 studied vessels 
showed complete occlusion, and forward flow was preserved in 
the rest of the vessels tudied. Therefore, it is unlikely that 
partial pressure of oxygen in the lumen of the distal segment 
was low. 
Another possibility is the modulation by constrictor sub- 
stances. Vascular endothelium has been known to release 
several constrictors, uch as prostanoids and endothelin (36). 
Platelets are another source of constrictors, uch as serotonin 
and thromboxane A2 (37). In the present study, the basal 
diameters of distal segments on the day after angioplasty were 
not different from those measured in the follow-up phase. 
Accordingly, the vasoconstrictor substances may have lost their 
major effect on the vasomotion of the distal vascular segment 
on the day after the relief rom ischemia. However, we cannot 
exclude the possibility that subthreshold concentrations of
vasoconstrictors that alone do not cause vasoconstriction may 
modulate vasomotion produced by substance P. Yang et al. 
(38) reported that a threshold concentration f endothelin-1 
potentiates contraction i duced by norepinephrine and sero- 
tonin. 
We may also need to consider the effect of angioplasty itself 
on the detected endothelial dysfunction. However, we do not 
think that the angioplasty procedure itself is the underlying 
mechanism of the blunted endothelium-dependent ilation for 
the following three reasons: 1) Neither coronary occlusion 
time, number of inflations nor maximal balloon inflation 
pressure on angioplasty correlated with the degree of endothe- 
lial dysfunction observed on the day after angioplasty. 2) The 
transstenotic pressure gradient and percent diameter stenosis 
were correlated to endothelial dysfunction. If the angioplasty 
procedure itself was the cause of the attenuated ndothelium- 
dependent reaction on the day after angioplasty, such a 
correlation would not have been observed. 3) Endothelial 
dysfunction i duced by brief coronary occlusion (15 min) has 
been shown to be restored to a normal evel within 2 h (31). 
Because we evaluated endothelial function on the day after 
angioplasty, it is unlikely that the angioplasty itself influenced 
our results. 
Thus, it is probable that the attenuated responses of distal 
vascular segments to substance P are caused by low perfusion 
pressure or low shear stress produced by critical organic 
stenosis, which leads to downregulation f constitutive nitric 
oxide synthase. Further studies hould be performed to eluci- 
date the exact mechanisms of the endothelial functional im- 
pairment in the vascular segments distal to stenosis. 
EI-Tamini et al. (39) investigated the effect of intracoronary 
acetylcholine in eight patients 8 days after successful angio- 
plasty. They found that the vascular segments distal to the 
angioplasty target lesion constricted more than nondilated 
vessels and target segments. These results are consistent with 
our results. EI-Tamini et al. (39) concluded that the enhanced 
constriction of the distal segment isdue to enhanced sensitivity 
of smooth muscle other than endothelium because dilated 
segments, the endothelium ofwhich was directly damaged by 
angioplasty, constricted less than the distal segments. Although 
we cannot directly compare our results with those of E1-Tamini 
et al. (39) because of the difference in agonist used (substance 
P vs. acetylcholine) and study performance (next day vs. 8 days 
after angioplasty), our results suggest the possibility that the 
enhanced constriction of distal segments o acetylcholine inthe 
study of E1-Tamini et al. reflect the endothelial dysfunction 
caused by repetitive chronic hypoperfusion. 
A recent study (40) that measured coronary flow has 
demonstrated the possibility that myocardial infarction re- 
duces coronary vasodilator function even in the chronic phase. 
However, in the present study, patients with myocardial syn- 
ergy also showed angioplasty-induced amelioration of endo- 
thelial function of the epicardial conduit vessel. The viability of 
infarcted myocardium orthe sizes of the vessels of interest may 
explain the differences. 
Basal tone of vascular segments after angioplasty. The 
baseline diameter of the epicardial coronary artery after 
angioplasty has been evaluated in previous tudies. Fischell et 
al. (41) demonstrated vasoconstriction of vascular segments 
distal to the target lesion 30 rain after angioplasty. E1-Tamini et 
al. (42) also detected constriction 4h after and recovery 8days 
after angioplasty. In the present study, the baseline diameter of 
the coronary artery distal to the target lesion was not different 
from that measured 3 months after angioplasty, suggesting that 
angioplasty-induced vasoconstriction i distal segments that 
persists for at least several hours is relieved within 24 h. 
Fischell et al. (41) speculated that vasoconstrictor substances 
derived from platelets or guide wire procedures are not likely 
to be the mechanism and that the blunted flow-mediated 
endothelium-dependent dilation underlies the mechanism. 
However, we demonstrated the presence of endothelial dys- 
function 1 day after angioplasty. The hierarchic structure inthe 
impairment of endothelium-dependent r sponses in patients 
with ischemic heart disease may explain this phenomenon. 
Zeiher et al. (29) found that flow-dependent vasodilation is 
more resistant to impairment than acetylcholine-induced va-
sodilation. Previous studies (17,33) showed that receptor- 
mediated endothelium-dependent ila ion is more susceptible 
to injury than non-receptor-dependent dothelium- 
dependent dilation. 
Limitations of the study. In the present study, patients with 
a variety of risk factors and with previous myocardial infarction 
were included. These factors may have affected the coronary 
vasomotion i the distal vascular segment. A relatively scat- 
tered degree of recovery of the endothelial function may have 
resulted from the diversity of the subjects. 
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The correlation between substance P-induced ilation and 
the transstenotic pressure gradient or lesion stenosis measured 
before angioplasty has demonstrated that the magnitude of 
endothelial dysfunction i patients with chronic stable angina 
is determined by the degree of low perfusion state. However, 
we cannot draw a conclusion about the mechanism of low 
perfusion-induced impairment of endothelial function from 
the present study. Experiments with excised coronary vascular 
rings from transplanted hearts from patients with ischemic 
heart disease might be useful to determine the exact mecha- 
nisms. 
Clinical significance. Coronary endothelial dysfunction is
one of the deleterious factors that produce myocardial dys- 
function (43). The present study demonstrated the possibility 
that chronic coronary hypoperfusion produces further endo- 
thelial dysfunction. Accordingly, endothelial dysfunction may 
form a vicious cycle, producing myocardial ischemia. Coronary 
angioplasty may be effective in blocking the progression of this 
cycle. Endothelial dysfunction ot only affects local vasomo- 
tion, but also leads to platelet hyperaggregation and hyperad- 
hesiveness, which tend to produce ischemic ardiac events (2). 
Accordingly, angioplasty may also be beneficial from the 
viewpoint of preventing coronary thrombosis. 
Several factors are known to ameliorate ndothelial dys- 
function. These include fish oil (44), cholesterol-reducing 
therapy (45), superoxide dismutase (46) and L-arginine (47). 
To our knowledge, the present report is the first to demon- 
strate that relief from chronic repetitive coronary hypoperfu- 
sion ameliorates ndothelial dysfunction i the distal segment 
of the culprit lesion. 
We are grateful to the staff and technicians of the catheterization laboratories of
the Tohoku University Hospital and Iwate Prefectural Central Hospital for their 
cooperation. We are also grateful to Brent Bell, BA for reading the manuscript. 
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